首页> 外文期刊>Clinical cardiology. >Differential prognostic effect of revascularization according to a simple comorbidity index in high-risk non-ST-segment elevation acute coronary syndrome
【24h】

Differential prognostic effect of revascularization according to a simple comorbidity index in high-risk non-ST-segment elevation acute coronary syndrome

机译:根据简单合并症指数进行的血运重建对高危非ST段抬高的急性冠脉综合征的预后不同

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Data on the effect of revascularization on outcome in patients with high-risk non-ST-segment elevation acute coronary syndrome (NSTEACS) and significant comorbidities are scarce. Recently, a simple comorbidity index (SCI) including 5 comorbidities (renal failure, dementia, peripheral artery disease, heart failure, and prior myocardial infarction [MI]) has shown to be a useful tool for risk stratification. Nevertheless, therapeutic implications have not been derived. Hypothesis: We sought to evaluate the prognostic effect attributable to revascularization in NSTEACS according the SCI score. Methods: We included 1017 consecutive patients with NSTEACS. The effect of revascularization on a combined end point of all-cause mortality or nonfatal MI was evaluated by Cox regression according to SCI categories. Results: A total of 560 (55.1%), 236 (23.2%), and 221 (21.7%) patients showed 0, 1, and ≥2 points according to the SCI, respectively. Coronary angiography was performed in 725 patients (71.5%), and 450 patients (44.3%) underwent revascularization. During a median follow-up of 16 months (interquartile range, 12-36 months), 305 (30%) patients experienced the combined end point (202 deaths [19.9%] and 170 MIs [16.7%]). In multivariate analysis, a differential prognostic effect of revascularization was observed comparing SCI ≥2 vs 0 (P for interaction = 0.008). Thus, revascularization was associated with a greater prognostic benefit in patients with SCI ≥2 (hazard ratio [HR]: 0.51, 95% confidence interval [CI]: 0.29-0.89), P = 0.018), whereas no significant benefit was observed in those with 0 and 1 point (HR: 1.31, 95% CI: 0.88-1.94, P = 0.171 and HR: 1.11, 95% CI: 0.70-1.76, P = 0.651, respectively). Conclusions: In NSTEACS, the SCI score appears to be a useful tool for identifying a subset of patients with a significant long-term death/MI risk reduction attributable to revascularization.
机译:背景:关于高血型非ST段抬高的急性冠状动脉综合征(NSTEACS)和严重合并症患者,血运重建对预后影响的数据很少。最近,包括5种合并症(肾衰竭,痴呆症,外周动脉疾病,心力衰竭和先前的心肌梗塞[MI])的简单合并症指数(SCI)已显示是用于风险分层的有用工具。然而,尚无治疗意义。假设:我们试图根据SCI评分评估归因于NSTEACS血运重建的预后效果。方法:我们纳入了1017例连续的NSTEACS患者。根据SCI类别,通过Cox回归评估了血运重建对全因死亡率或非致命性MI合并终点的影响。结果:根据SCI,分别有560名(55.1%),236名(23.2%)和221名(21.7%)患者显示0、1和≥2分。 725例患者(占71.5%)进行了冠状动脉造影,而450例患者(占44.3%)进行了血运重建。在16个月的中位随访期间(四分位间距为12-36个月),有305名(30%)患者经历了合并终点(202例死亡[19.9%]和170例MIs [16.7%])。在多变量分析中,比较SCI≥2 vs 0(交互作用P = 0.008),观察到血运重建的预后差异。因此,血运重建与SCI≥2的患者的预后获益更大(危险比[HR]:0.51,95%置信区间[CI]:0.29-0.89),P = 0.018),而在SCI≥2的患者中未观察到明显的获益。得分为0和1的人群(HR:1.31,95%CI:0.88-1.94,P = 0.171和HR:1.11,95%CI:0.70-1.76,P = 0.651)。结论:在NSTEACS中,SCI评分似乎是一种有用的工具,可用于识别因血运重建而导致长期死亡/ MI风险显着降低的部分患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号